Skip to content
Anna P. Durbin, M.D.
- Professor, International Health, Johns Hopkins Univ.
- Co-developer of the NIH dengue vaccine
- Expert on clinical trials of viral vaccines
Thomas Forest Farb-Horch
- Co-founder, President & CEO, Thrive Bioscience
- Senior executive & founder of 10 companies (>35 yrs)
Alexander Kabanov, Ph.D.
- M. S. Ferguson Distinguished Professor, School of Pharmacy, Univ. of North Carolina – Chapel Hill
- Director, Center Nanotechnology in Drug Delivery, UNC
- Co-Director, Carolina Institute for Nanomedicine
Gary Kobinger, Ph.D.
- Director of the Galveston National Laboratory
- Chief of the Special Pathogens BSL-4 program, Canadian National Microbiology Laboratory (2008 – 2016)
- Co-chair of the WHO Emerging and Dangerous Pathogens Laboratory Global Network for Outbreak Response and Readiness (2008 – 2014)
Thomas Monath, M.D.
- Legendary vaccinologist
- Chief Development Officer at Vaxxinity Inc.
- Managing Partner and CSO at Crozet BioPharma LLC
- Past-President and Fellow American Soc. of Tropical Medicine and Hygiene
Robin Robinson 1st, Ph.D.
- CSO RenovaCare, Inc.
- Founding Director of BARDA (2008 – 2016)
- Deputy Assistant Secretary – HHS/ASPR & Director – HHS/ASPR/BARDA (2008 – 2016)
- Director – Influenza Division, U.S. DHHS (2004 – 2014)
Alessandro Sette, Dr.Biol.Sci.
- LaJolla Institute for Immunology
- Top expert on T cell response against viral infections
